Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
48.20
-1.57 (-3.15%)
At close: Aug 24, 2026

SHE:301096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
396.51292.6428.97881.931,2392,013
Trading Asset Securities
608083---
Cash & Short-Term Investments
456.51372.6511.97881.931,2392,013
Cash Growth
-10.99%-27.22%-41.95%-28.81%-38.46%1406.49%
Accounts Receivable
955.75902744.4532.18254.49124.41
Other Receivables
2.819.763.164.14.794.1
Receivables
958.57911.77747.56536.28259.28128.5
Inventory
180.11176.44177.3493.1766.0522.85
Prepaid Expenses
----1.83-
Other Current Assets
103.2291.28108.6196.443.9461.2
Total Current Assets
1,6981,5521,5451,6081,6102,226
Property, Plant & Equipment
1,7421,7771,8321,7411,075566.63
Long-Term Investments
16.4202.5187.78136.8781.125.77
Other Intangible Assets
89.1389.893.4392.0782.3760.79
Long-Term Accounts Receivable
----1.911.95
Long-Term Deferred Tax Assets
37.4336.8735.5548.4353.4122.86
Long-Term Deferred Charges
0.931.081.420.253.9914.41
Other Long-Term Assets
218.0127.0525.843.1421.626.92
Total Assets
3,8023,6863,7213,6692,9302,925

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
105.3248.7841.82130.25167.0312.64
Accrued Expenses
16.1630.9839.973.444.6954.8
Short-Term Debt
518.13510.61360.08369.32-5.01
Current Portion of Long-Term Debt
179.56169.74104.25--220.32
Current Portion of Leases
-0.620.730.388.848.8
Current Income Taxes Payable
2.66-0.035.065.736.17
Current Unearned Revenue
81.9476.06112.4274.0162.6171.17
Other Current Liabilities
2.6983.12110.14193.771.893.79
Total Current Liabilities
906.46919.91769.38846.19290.7472.69
Long-Term Debt
310.01189.51244--40.44
Long-Term Leases
2.52.342.920.93-8.14
Long-Term Unearned Revenue
21.7823.7231.4840.671.45-
Long-Term Deferred Tax Liabilities
----4.320.01
Other Long-Term Liabilities
59.8661.8494.0297.17150.9785.83
Total Liabilities
1,3011,1971,142984.97447.45607.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
109.23109.23109.23108.92108.17108.17
Additional Paid-In Capital
2,1072,1072,1072,1272,0612,026
Retained Earnings
335.91323.09413.49498.68313.24183.98
Treasury Stock
-50-50-50-50--
Comprehensive Income & Other
-0.17-0.18-0.14-0.14--
Total Common Equity
2,5022,4892,5792,6842,4832,318
Minority Interest
-----0.26-0.14
Shareholders' Equity
2,5022,4892,5792,6842,4822,318
Total Liabilities & Equity
3,8023,6863,7213,6692,9302,925

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
1,010872.82711.99370.648.84282.7
Net Cash (Debt)
-553.69-500.22-200.02511.291,2301,730
Net Cash Growth
----58.43%-28.92%-
Net Cash Per Share
-5.09-4.59-1.864.7211.3421.34
Filing Date Shares Outstanding
108.45108.45108.45108.14108.17108.17
Total Common Shares Outstanding
108.45108.45108.45108.14108.17108.17
Working Capital
791.96632.17776.1761.591,3191,753
Book Value Per Share
23.0722.9523.7824.8222.9521.43
Tangible Book Value
2,4132,3992,4862,5922,4002,257
Tangible Book Value Per Share
22.2522.1222.9223.9722.1920.87
Buildings
-980.29863.44859.97196.19196.14
Machinery
-1,1941,079629.9642.96319.94
Construction In Progress
-66.67206.66448.82546.21104.08